|
Post by Maxx on Jun 14, 2010 13:27:15 GMT -5
A drug commonly used to treat blood pressure, heart failure and diabetes-related kidney damage, was linked to a “modest” increased risk of cancer in a study published Monday. The Lancet Oncology journal’s research on the use of angiotensin receptor blockers (ARBs) found 7.2 percent of patients who took ARBs were given a new cancer diagnosis, compared to 6 percent of patients not treated with ARBs, over the same four-year period. The U.S. study described the results as showing “ARBs are associated with a modestly increased risk of new cancer diagnosis,” and said the findings warrant further investigation. Of the specific solid organ cancers examined, only instances of lung cancer were significantly higher in the patients assigned ARBs. www.foxnews.com/story/0,2933,594562,00.html
|
|